Russia’s first commercial early-stage clinical trial center launched in St. Pete
09 April 2014
Russia’s first commercial R&D center for early-stage clinical trials opened in St. Petersburg last week as a joint project between the state-owned RVC Biofund and its portfolio company, BioEc, the RVC website announced .
New atherosclerosis therapy nears in vitro test phase in Siberia
09 April 2014
Scientists at Tomsk Polytechnic University and the local Research Institute of Cardiology are developing a new method of treating atherosclerosis using a coronary stent with a biodegradable coating, reported the website of Vesti-Tomsk, a regional TV and radio broadcasting company.
Duke spinout Regado files to raise up to $69M in new offering
05 April 2014
Duke University spinout Regado Biosciences has filed notice to sell new shares on the open market.
Syndax Plots $69M IPO For Cancer Drug’s Stretch Run
28 March 2014
Syndax Pharmaceuticals raised about $27 million in private financing last year to gear up for a late-stage clinical trial. Now, on the doorstep of that lengthy, 600-patient study, the Waltham, MA-based company is looking to Wall Street to get it to the finish line.
Syndax Files Registration Statement for Proposed Initial Public Offering
27 March 2014
Syndax Pharmaceuticals, Inc. today announced that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (“SEC”) relating to a proposed initial public offering of shares of its common stock. All shares of common stock to be sold in the offering will be offered by Syndax. The number of shares to be offered and the price range for the offering have not yet been determined.
Siberians seek funding as they develop solution to many medical problems
26 March 2014
Scientists in Novosibirsk are seeking a Russian Scientific Fund grant in an effort to create a cell bank—a key to faster identification of most working therapies for a variety of human diseases, Nanonewsnet.ru reported , citing Academician Valentin Vlasov, the director of the local Institute of Chemical Biology and Fundamental Medicine.
Ministry of Health estimated the continued modernization of health trillion rubles
25 March 2014
For modernization of fixed assets of the Russian health care system require more than one trillion rubles. So appreciated investment required deputy Sergei Regional Ministry of Health , according to ITAR -TASS.
ECOG-ACRIN Opens Phase III Trial of Syndax’s Entinostat in Advanced Breast Cancer
20 March 2014
Entinostat is being investigated in patients with advanced hormone receptor-positive breast cancer by the ECOG-ACRIN Cancer Research Group in its latest trial, E2112.
Generic-Drug Testing Goes Widespread in U.S. FDA Effort
25 February 2014
Generic drugs that make up almost 80 percent of U.S. prescriptions are being tested in the first widespread safety and quality evaluation run by the Food and Drug Administration.
18 February 2014
In 2013, the U.S. Food and Drug Administration (FDA) approved 27 New Molecular Entities (NMEs).
NovaMedica expands its line of products for the treatment of Alzheimer’s disease
22 August 2024
Children visited the NovaMedica Innotech pharmaceutical manufacturing facility
14 June 2024
16 May 2024
06 September 2024
HPV vaccine is to be included in Russia’s national immunization schedule by 2026
06 September 2024
New WHO guidance to support manufacturers to reduce AMR risk
05 September 2024
05 September 2024